Ashurst has advised an international banking consortium comprising Commerzbank Aktiengesellschaft as technical lead, Deutsche Bank AG, London Branch, DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main and Landesbank Hessen-Thüringen Girozentrale on the successful issuance of a €350 million 5-year corporate bond by STADA Arzneimittel AG (STADA). Interest on the bond is 2.250 per cent. per annum.

STADA Arzneimittel AG having its seat in Bad Vilbel, Hesse, is one of the largest producers of generic products worldwide and has an extensive portfolio of pharmaceutical and cosmetic brand products.

The Ashurst team was led by Frankfurt-based partner Christoph Enderstein (Debt Capital Markets), supported by associates Dr Angela Brücken and Nico Feuerstein.

The German debt capital markets practice of Ashurst advises both investment banks and issuers in connection with national and international capital market transactions, in particular regarding bonds, securitised derivatives, German Schuldschein loans and debt issuance programmes as well as on related regulatory matters. According to a survey carried out by financial services information provider Thomson Reuters, the debt capital markets team headed by Christoph Enderstein was the most active legal adviser in 2012 in connection with bonds in Germany.

http://www.ashurst.com/media-item.aspx?id_Content=9369&expandOfficeList…